Progressive, your share totals for Leo and Dr. Menon are beneficially owned and include their options. The float is about 52.5 million shares.
10-Q for the period endind 9/30/12 reveals -
http://www.sec.gov/Archives/edgar/data/135525...12_10q.htm
Common Stock - 95,886,235 + (2,000,000 options excercized in December) = 97,886,235 shares O/S Preferred Stock - 0
Page 63 of the last 10-K revaels -
http://www.sec.gov/Archives/edgar/data/135525...12_10k.htm
Dr. Menon - 49,048,286 shares beneficially owned Krishna Menon, Chief Scientific Officer. Includes 18,000,000 vested options granted to him under the 2010 Equity Inventive Plan currently exercisable. - 18,000,000 options = 31,048,286 shares
Leo Ehrlich - 36,251,812 shares beneficially owned Leo Ehrlich, CEO, Chief Financial Officer and Director. (i) Includes 8,745,002 shares of Cellceutix common stock held by Mr. Ehrlich, (ii) includes 3,502,282 shares of Cellceutix’s common stock held by the wife and child of Leo Ehrlich, (iii) includes 4,004,528 shares of common stock into which the convertible loan in the amount of $2,002,264 would be convertible at $.50 per share deemed to be outstanding, (iv) includes 18,000,000 vested options granted to him under the 2010 Equity Incentive Plan currently excercisable and (v) includes 2,000,000 shares of common stock issued to him on May 8, 2012 - 22,004,528 options = 14,247,284 shares
Float = 97,886,235 shares O/S - minus Leo's (and family) 14,247,284 and Dr. Menon's 31,048,286 = 52,590,665 Float
